Tags Archive Navigation
icon
-
StoryA legacy of blood cancer innovation
-
StoryA personal journey full circle, from curiosity about life on Earth to transformative therapies at Novartis
-
StoryHow collaboration can enhance your science career
-
Media ReleaseNovartis appoints Fiona Marshall, Ph.D., President of the Novartis Institutes for BioMedical Research as Jay Bradner, M.D., steps down from the Executive Committee of Novartis
-
StoryA scientist from the start – Q&A with NIBR President Fiona Marshall
-
StoryThe art of drug design in a technological age
-
StoryStopping this coronavirus – and the next one
-
Media ReleaseNovartis announces collaboration with Molecular Partners to develop two DARPin® therapies designed for potential use against COVID-19
-
Media ReleaseSandoz confirms late-stage clinical development plans for proposed biosimilar aflibercept, a key ophthalmology medicine
-
StoryThe future of chronic myeloid leukemia is evolving
-
StoryStriving to vanquish leukemia
-
StoryNovartis and UC Berkeley take on “undruggable” proteins in new collaboration